Keith Katkin, President and CEO at AVANIR PHARMACEUTICALS, INC. (AVNR), bought 10,000 shares at $2.61 ($26K) on 2012-03-06, disclosed to the SEC on 2012-03-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SNDX | BUY | 2025-05-19 | $91K | — | Filing → |
| SNDX | SELL | 2022-10-07 | $1.5M | — | Filing → |
| SNDX | SELL | 2022-10-04 | $176K | — | Filing → |